Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 9, 2008
Cirrhosis-like radiological pattern in patients with breast cancerCésar Gómez Raposo, Andrés Redondo Sánchez, Félix Guerra-Gutiérrez, et al.
Future Oncology (London, England)|October 4, 2019
Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patientsLucía Trilla-Fuertes, Angelo Gámez-Pozo, Mariana Díaz-Almirón, et al.
Plos One|September 9, 2017
Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancerAlberto Peláez-García, Laura Yébenes, Alberto Berjón, et al.
Clinical Nuclear Medicine|September 21, 2006
Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic diseaseMónica Coronado, Andrés Redondo, Juan Coya, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 26, 2022
Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancerElena López-Camacho, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, et al.
Cancer Biomarkers : Section a of Disease Markers|May 25, 2007
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish womenJosé I Martinez-Ferrandis, Raquel Rodríguez-López, Roger L Milne, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 2, 2024
Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breastJavier Álvarez Criado, Pilar Zamora Auñon, Virginia Martínez Marín, et al.
Plos One|June 24, 2009
Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancerEnrique Espinosa, Iker Sánchez-Navarro, Angelo Gámez-Pozo, et al.
Oncotarget|July 3, 2018
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancerAndrea Zapater-Moros, Angelo Gámez-Pozo, Guillermo Prado-Vázquez, et al.
Pageof 13